South Korea's Daesang shifts amino acid focus to pharmaceutical grade after German acquisition
10 Sept 2026
The feed-grade lysine producer will make raw material in Korea and purify at AMINO GmbH's plant in Germany, targeting medical and biopharmaceutical markets.
Related Articles
South Korea's ageing hanwoo farms: 55.3% of operators are 65 or older and 72% have no successor
8 Nov 2026
South Korea lifts culling compensation cap to 90% and moves to risk-based culling in livestock disease overhaul
7 Nov 2026
South Korea's Daesang ships first lysine batch to Brazil after securing export approval
6 Nov 2026